These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4851019)

  • 1. Chromosome abnormalities from cyclophosphamide therapy in rheumatoid arthritis and progressive systemic sclerosis (scleroderma).
    Tolchin SF; Winkelstein A; Rodnan GP; Pan SF; Nankin HR
    Arthritis Rheum; 1974; 17(4):375-82. PubMed ID: 4851019
    [No Abstract]   [Full Text] [Related]  

  • 2. Chromosomal breakage in systemic sclerosis and related disorders.
    Emerit I
    Dermatologica; 1976; 153(3):145-56. PubMed ID: 14037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of immunosuppression: effects of cyclophosphamide on lymphocytes.
    Winkelstein A; Mikulla JM; Nankin HR; Pollock BH; Stolzer BL
    J Lab Clin Med; 1972 Oct; 80(4):506-13. PubMed ID: 5073893
    [No Abstract]   [Full Text] [Related]  

  • 4. Breakage factor in systemic sclerosis and protector effect of L-cysteine.
    Emerit I; Levy A; Housset E
    Humangenetik; 1974; 25(3):221-6. PubMed ID: 4448453
    [No Abstract]   [Full Text] [Related]  

  • 5. Chromosome 5 inversion in two siblings, one with Klinefelter syndrome and systemic sclerosis, the other with rheumatoid arthritis.
    Bargagli E; Bartalini G; Galeazzi M; Maggiorelli C; Anichini C; Rottoli P
    Rheumatol Int; 2008 May; 28(7):725-6. PubMed ID: 18092168
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of therapeutic and cytogenetic effect of intra-articular cyclophosphamide injections in complex rheumatoid arthritis treatment in children].
    Melikhova NI; Zhurkov VS; Ivanova IuE
    Vopr Revm; 1977; (2):51-5. PubMed ID: 898811
    [No Abstract]   [Full Text] [Related]  

  • 7. Chromosome abnormalities in peripheral lymphocytes from patients with progressive systemic sclerosis.
    Takeuchi F; Nakano K; Yamada H; Kosuge E; Hirai M; Maeda H; Moroi Y
    Rheumatol Int; 1993; 12(6):243-6. PubMed ID: 8484097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chromosome abnormalities in systemic scleroderma].
    Emerit I; Camus JP
    Rev Rhum Mal Osteoartic; 1972 Nov; 39(11):731-4. PubMed ID: 4654971
    [No Abstract]   [Full Text] [Related]  

  • 9. Spontaneous and X-ray induced chromosomal aberrations in selected connective tissue diseases.
    Burkhardt WC; Jackson JF; Songcharoen S; Meydrech EF
    Clin Genet; 1980 Feb; 17(2):108-14. PubMed ID: 7363495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dominant lethal assay in the mouse.
    Bateman AJ
    Agents Actions; 1973 Jun; 3(2):73-6. PubMed ID: 4737850
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chromosome studies of collagen diseases].
    Emerit I; Feingold J; Camus JP; Housset E
    Ann Genet; 1974 Dec; 17(4):251-6. PubMed ID: 4155934
    [No Abstract]   [Full Text] [Related]  

  • 12. The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens.
    Hazleman BL
    Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):12-7. PubMed ID: 7039526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regional intra-articular treatment of rheumatoid arthritis with different drugs, especially with immunosuppressive agents].
    Anastasescu G; Marin D
    Med Interna (Bucur); 1969 May; 21(5):597-600. PubMed ID: 5344552
    [No Abstract]   [Full Text] [Related]  

  • 14. Chromosomal abnormalities in progressive systemic sclerosis (scleroderma) with consideration of radiation effects.
    Pan SF; Rodnan GP; Deutsch M; Wald N
    J Lab Clin Med; 1975 Aug; 86(2):300-8. PubMed ID: 1151153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-penicillamine in the treatment of rheumatoid arthritis and progressive systemic sclerosis.
    Davis P; Bleehen SS
    Br J Dermatol; 1976 Jun; 94(6):705-11. PubMed ID: 779821
    [No Abstract]   [Full Text] [Related]  

  • 16. [Long-term, small-dose cyclophosphamide treatment of severe inflammatory joint diseases].
    Chaouat Y; Paquet J; Pélisson J; Kanovitch B; Rascovscki S
    Rev Rhum Mal Osteoartic; 1968 Dec; 35(12):649-56. PubMed ID: 5717215
    [No Abstract]   [Full Text] [Related]  

  • 17. Chromosome instability in human and murine autoimmune disease: anticlastogenic effect of superoxide dismutase.
    Emerit I; Michelson AM
    Acta Physiol Scand Suppl; 1980; 492():59-65. PubMed ID: 6939306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial occurrence of systemic sclerosis, rheumatoid arthritis and other immunological disorders: report of two kindreds with study of HLA antigens and review of the literature.
    Molta CT; Khan MA; Aponte CJ; Reynolds TL; Macintyre SS
    Clin Exp Rheumatol; 1989; 7(3):229-36. PubMed ID: 2667829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA phenotype and systemic sclerosis-rheumatoid arthritis overlap syndrome: comment on the article by Horiki et al.
    Yasunaga S; Higuchi M; Nishizaka H; Yoshizawa S; Horiuchi T
    Arthritis Rheum; 1998 Apr; 41(4):757-8. PubMed ID: 9550496
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rheumatoid arthritis, progressive systemic sclerosis without skin involvement and mixed collagen disease in a family. Clinical description of a mother and her 3 adult children--studies of HLA antigens and review of the literature].
    Stockmann G; Franke M; Kasulke D
    Z Rheumatol; 1986; 45(1):16-25. PubMed ID: 3705774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.